Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi
about
In vitro activities of 11 fluoroquinolones against 816 non-typhoidal strains of Salmonella enterica isolated from Finnish patients with special reference to reduced ciprofloxacin susceptibility.Enteric fever in India: current scenario and future directionsA multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in VietnamInduction of resistant mutants of Salmonella enterica serotype Typhi under ciprofloxacin selective pressureMolecular basis of resistance displayed by highly ciprofloxacin-resistant Salmonella enterica serovar Typhi in BangladeshEfficacy of Ciprofloxacin for Treatment of Cholera Associated with Diminished Susceptibility to Ciprofloxacin to Vibrio cholerae O1Typhoidal Salmonellae: Use of Multi-Locus Sequence Typing to Determine Population Structure.Acute Hepatic Necrosis Caused by Salmonella enterica Serotype I 4,5,12:-:1,2 in a Dog.Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study.In vitro susceptibility testing of fluoroquinolone activity against Salmonella: recent changes to CLSI standards.Antimicrobial resistance in Salmonella enterica serovar typhi and paratyphi in South Asia-current status, issues and prospects.Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: the impact on clinical outcome and future treatment options.Study of Clinical Profile and Antibiotic Sensitivity Pattern in Culture-positive Typhoid Fever Cases.Enteric fever in a 6-year-old traveler caused by Salmonella enterica serotypes Typhi and Paratyphi A: laboratory detection strategies and treatment options.Profile of Culture Positive Enteric Fever from BangaloreEnteric fever due to Salmonella Paratyphi A in Greece: a case report.Surveillance of antimicrobial resistance of Salmonella enterica serotype Typhi in seven Asian countries.Epidemiological shift, seasonal variation and antimicrobial susceptibility patterns among enteric fever pathogens in South India.Development of a real-time PCR assay for detection of gyrA mutations associated with reduced susceptibility to ciprofloxacin in Salmonella enterica serovar typhi and paratyphi A.Pefloxacin as a surrogate marker for quinolone susceptibility in Salmonella enterica serovars Typhi & Paratyphi A in IndiaQuinolone resistance of Salmonella enterica serovar Virchow isolates from humans and poultry in Israel: evidence for clonal expansionEmergence of fluoroquinolone resistance in Salmonella enterica serovar Typhi in Andaman and Nicobar Islands, IndiaEnteric Fever Caused by Salmonella enterica Serovars with Reduced Susceptibility of Fluoroquinolones at a Community Based Teaching Hospital of Nepal.Prevalence and risk factors for quinolone resistance among Escherichia coli strains isolated from males with community febrile urinary tract infection.
P2860
Q24812949-FB831FC8-9A6C-433D-B5E6-EE915E163465Q28070030-589027BB-3B2F-42E3-95DC-B497A55C7A53Q28472731-692C4F4D-3CCF-48B2-A372-31C898148713Q34073057-B3E17B19-BE55-4910-8C65-96BA308A1E92Q35073518-38F5AD3E-28C7-4077-8CAF-08A48787C5CDQ35745227-63A27457-905E-4661-AED2-1E821662D714Q36130111-4941BCEA-DEC8-4CE1-B422-2F14E6796F2FQ36173934-B96AF6B4-541B-4C35-966B-91E55F079EB8Q36538683-7EB7AFD3-0553-45F1-977C-D999CEAEAD24Q38023251-72E11096-BDA7-4144-8975-651F2E520BA4Q38197212-44120960-3AE8-44A5-AF6F-CB883D9A4302Q39431565-1B994C03-1578-4C33-A015-EBCEDE07F9EEQ40261912-E93976D5-6DF9-4C3C-9D3F-034CB6908767Q40345197-EA327422-3640-4A22-8DA5-84ABFD8F0D2AQ40378632-2EC9CA02-AFEC-49C1-B243-FA0FA77BBAEEQ40402088-F6A9019B-853C-46FA-AA00-62EC35E8431AQ40419371-2B8D80EC-9A60-4C6E-9618-7F1AA9C58C47Q40420077-A2866F77-84F7-4FF3-8A02-898AA3689511Q40469531-4A2EE2FB-01BE-4BB6-A238-E8C0AD5F5871Q41928922-D50147CC-9E61-43C8-953F-294AE1684F16Q42413026-03807B60-0AD6-4BE9-8C23-0B3CC3719E25Q42540420-6C3820EE-5D12-4A21-8CBF-A061F8205A4BQ46130963-39B748C9-B335-46E2-88C7-8F9D0BE46D84Q54357049-F1425F3A-5218-4480-8AD0-99D686791B0B
P2860
Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Clinical outcomes in typhoid f ...... cid-resistant Salmonella typhi
@ast
Clinical outcomes in typhoid f ...... cid-resistant Salmonella typhi
@en
Clinical outcomes in typhoid f ...... cid-resistant Salmonella typhi
@nl
type
label
Clinical outcomes in typhoid f ...... cid-resistant Salmonella typhi
@ast
Clinical outcomes in typhoid f ...... cid-resistant Salmonella typhi
@en
Clinical outcomes in typhoid f ...... cid-resistant Salmonella typhi
@nl
prefLabel
Clinical outcomes in typhoid f ...... cid-resistant Salmonella typhi
@ast
Clinical outcomes in typhoid f ...... cid-resistant Salmonella typhi
@en
Clinical outcomes in typhoid f ...... cid-resistant Salmonella typhi
@nl
P2093
P2860
P3181
P356
P1476
Clinical outcomes in typhoid f ...... cid-resistant Salmonella typhi
@en
P2093
P2860
P2888
P3181
P356
10.1186/1471-2334-5-37
P407
P577
2005-05-18T00:00:00Z
P5875
P6179
1004854501